ArticleFrontiers in endocrinology2026

Stigmasterol ameliorates obesity-associated insulin resistance by activating the PPARγ pathway and alleviating oxidative stress.

Yanan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.